29-Aug-2016 - ACD/Labs’ flagship product ACD/ChemSketch allows pharmaceutical scientists to “better understand the fate of molecules,” says the company president.
25-Aug-2016 - Metrion Biosciences (Metrion), an ion-channel and drug discovery CRO, has joined a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research.
24-Aug-2016 - AMRI and the University at Albany’s RNA Institute are partnering to speed the development of new RNA-based therapeutics in an “ideal and first of its kind” collaboration.
23-Aug-2016 - AMRI has entered into an agreement to license CRISPR-Cas9 gene editing technology from the Broad Institute of MIT and Harvard.
16-Aug-2016 - Crown Bioscience has expanded its oncology services with new models, cell lines, and assays at its San Diego-based Center of Excellence for Oncology.
09-Aug-2016 - Charles River Laboratories has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium and will provide the organization with access to its resources and services.
09-Aug-2016 - The global contract research organization (CRO) is increasing its focus on hepatotoxicity, one of the leading causes of adverse events in clinical trials.
05-Aug-2016 - Envigo recently announced the two of its sites have earned accreditation from the lab animal treatment watchdog, AAALAC.
04-Aug-2016 - Charles River says it is capitalising on the growing number of biologics in development, with its manufacturing business seeing double-digit growth led by demand for biosafety and cell banking services....
29-Jul-2016 - The first of its kind trial has successfully identified several compounds to pursue and has given rise to more than a dozen drug development projects.
27-Jul-2016 - Crown Bioscience has expanded its San Diego facility to create its US Center of Excellence for Oncology in order to support increasing demand for oncology research studies.
22-Jul-2016 - The EMA is recommending the suspension of several medicines after inspections revealed flawed studies at the India-based contract research organization (CRO), Semler Research Centre.
21-Jul-2016 - Mitsubishi Tanabe has joined the Simcyp Consortium – gaining a license to the modeling and simulation group’s pharmacokinetic prediction technology.
20-Jul-2016 - Exco InTouch has completed a HIPAA Privacy audit as the company continues to prepare for impending data protection regulations.
20-Jul-2016 - Envigo has announced that its sites in Bresso, Italy and Wyton, UK have earned their accreditation from the lab animal treatment watchdog, AAALAC.
18-Jul-2016 - A newly-launched international project seeks to develop a new bank of cancer cell culture models for the research community.
14-Jul-2016 - The FDA has issued two new guidances as part of the President’s Precision Medicine Initiative.
11-Jul-2016 - CrownBio’s new stable cell lines feature various immune checkpoints and receptors which are key targets and pathways for oncology drug discovery and development.
29-Jun-2016 - Researchers supported by the National Institutes of Health (NIH) have developed a clinical-grade stem cell line, which will help accelerate early-stage clinical research.
16-Jun-2016 - Crown Bioscience has expanded its immuno-oncology platform at its facilities in Europe, the US, and Asia to include immunophenotyping analysis.
15-Jun-2016 - Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.
15-Jun-2016 - As a dedicated Chemical Biology Consortium center, AMRI will provide a variety of drug discovery services to help advance early stage drug discovery projects.
13-Jun-2016 - WuXi AppTec has adopted Elsevier’s technology as the company begins to focus less on point solutions, and more on provider partnerships, says VP of procurement.
02-Jun-2016 - Sensors, computer vision, machine learning, and cloud computing are enabling preclinical researchers to conduct higher quality studies in a shorter period of time.
01-Jun-2016 - Rising drug prices and the subsequent increasing number of drugs ineligible for reimbursement will challenge drug developers to provide clinical superiority evidence.